Navigating Immunotoxicities from Cancer Treatment (NICT) DCN 2025

February 28, 2025 to March 1, 2025

Immunotherapeutic approaches to cancer treatment use a patient's own immune system to target cancer cells. The side effects associated with traditional treatment options such as chemotherapy and radiation make immunotherapeutic options appealing. The immune system can identify cancer cells in one of two ways: by recognizing tumor-specific antigens or mutations or by recognizing tumor associated antigens. Immunotherapy offers effective treatment options for cancer that offer long-lasting effects with improved overall survival and treatment tolerance. Immunotherapy can also cause organ specific toxicities or immune related adverse events. The recognition of these toxicities and their management is forefront for the clinicians caring for the oncology patient. The Duke Cancer Institute Center for Immunotherapy and the Duke Cancer Network are partnering to utilize a multidisciplinary team of oncology and immunology experts and researchers to educate on immunotoxicities occurring in cancer patients as well as management for these toxicities.

Target Audience

Identifying common immune related adverse events seen from the use of cancer immunotherapeutic agents.
Recognizing various immunotoxicities effect on specific organ systems.
Examining organ-specific clinical cases, diagnostic tests and current guidelines used to guide management and treatment of the patient experiencing an immune-related adverse event.

Course summary

Available credit:

Registration Opens:

03/01/2025

Registration Expires:

02/28/2026

Activity Starts:

02/28/2025 - 7:00am EST

Activity Ends:

03/01/2025 - 7:00am EST

Add to calendar:

Rating:

Durham, NC 27705

United States

Please login or register to take this course.